Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis

Thorax

Volumn 64, Issue 6, 2009, Pages 467-475

  Oikonomou, N ^e   Thanasopoulou, A ^e   Tzouvelekis, A ^a   Harokopos, V ^e   Paparountas, T ^e   Nikitopoulou, I ^e   Witke, W ^b   Karameris, A ^c   Kotanidou, A ^d   Bouros, D ^a   Aidinis, V ^e  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^c Veterans Administration Hospital (NIMTS)   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CASPASE 3; GELSOLIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROBLAST; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LEUKOCYTE MIGRATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

EID: 67249162070     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.107946     Document Type: Article

References (35)

1. Tesfaigzi Y. Roles of apoptosis in airway epithelia. Am J Respir Cell Mol Biol 2006;34:537-547
2. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-525 (Pubitemid 32758505)
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151 (Pubitemid 32096342)
4. Oikonomou N, Harokopos V, Zalevsky J, et al. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS ONE 2006;1:e108.
5. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006;3:364-372
6. Tzouvelekis A, Harokopos V, Paparountas T, et al. Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor 1α in disease pathogenesis. Am J Respir Crit Care Med 2007;176:1108-1119 (Pubitemid 350223757)
7. Barbas-Filho JV, Ferreira MA, Sesso A, et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 2001;54:132-138 (Pubitemid 32128415)
8. Hagimoto N, Kuwano K, Kawasaki M, et al. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am J Respir Cell Mol Biol 1999;21:436-445 (Pubitemid 129517199)
9. Plataki M, Koutsopoulos A, Darivianaki K, et al. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005;127:266-274 (Pubitemid 41724587)
10. Hagimoto N, Kuwano K, Nomoto Y, et al. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997;16:91-101. (Pubitemid 127497440)
11. Kuwano K, Kunitake R, Maeyama T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Cell Mol Physiol 2001;280:L316-25. (Pubitemid 32473224)
12. Gourlay CW, Ayscough KR. A role for actin in aging and apoptosis. Biochem Soc Trans 2005;33:1260-1264 (Pubitemid 41779662)
13. Dos Remedios CG, Chhabra D, Kekic MI, et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2002;83:433-473
14. Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999;11:103-108 (Pubitemid 29084137)
15. Kothakota S, Azuma T, Reinhard C, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278:294-298 (Pubitemid 27450877)
16. Geng YJ, Azuma T, Tang JX, et al. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol 1998;77:294-302. (Pubitemid 29017163)
17. Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 2002;19:794-796 (Pubitemid 34567889)
18. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8:1323-1327 (Pubitemid 35373567)
19. Witke W, Sharpe AH, Hartwing JH, et al. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995;81:41-51.
20. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 2006;26:307-316 (Pubitemid 44423549)
21. Azuma T, Koths K, Flanagan L, et al. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J Biol Chem 2000;275:3761-3766 (Pubitemid 30094596)
22. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol 2008;294:L601-11.
23. Vernooy JHJ, Dentener MA, Jan van Suylen R, et al. Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells. Am J Respir Cell Mol Bio 2001;24:569-576
24. Bouros D. Current classification of idiopathic interstitial pneumonias. Monaldi Arch Chest Dis 2000;55:450-454 (Pubitemid 32162176)
25. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-537
26. Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002;83:111-119 (Pubitemid 35286131)
27. Taooka Y, Maeda A, Hiyama K, et al. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 1997;156:260-265 (Pubitemid 27293199)
28. Yasui HGEC, Tamaki S, Kobayashi T, et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001;163:1660-1668 (Pubitemid 32578773)
29. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100. (Pubitemid 36511834)
30. Becker PM, Kazi AA, Wadgaonkar R, et al. Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol 2003;28:478-484 (Pubitemid 36399370)
31. Aidinis V, Carninci P, Armaka M, et al. Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. PLoS Genet 2005;1:e48.
32. Tran PL, Weinbach J, Opolon P, et al. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J Clin Invest 1997;99:608-617 (Pubitemid 27097661)
33. Spinardi L, Witke W. Gelsolin and diseases. Subcell Biochem 2007;45:55-69.
34. Goetzl EJ, Lee H, Azuma T, et al. Gelsolin binding and cellular presentation of lysophosphatidic acid. J Biol Chem 2000;275:14573-14578 (Pubitemid 30339747)
35. Tager AM, LaCamera P, Shea BS, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45-54.